Pulmonary hypertension secondary to COPD

Keyphrases

• Pulmonary Hypertension 100%
• Long-term Oxygen Therapy 100%
• Statins 50%
• Endothelial Dysfunction 50%
• Exercise Capacity 50%
• Survivability 50%
• Antiproliferative Properties 50%
• Selective Pulmonary Vasodilator 50%
• Elevated Pulmonary Artery Pressure 50%
• Endothelial Inflammation 50%
• Severe Exacerbation 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Obstructive Lung Disease 100%
• Pulmonary Hypertension 100%
• Inflammation 33%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 33%
• Endothelial Dysfunction 33%
• Peripheral Vasodilating Agent 33%
• Pathogenesis 33%